Exciting current topics in lung cancer
Tremelimumab and durvalumab therapy in lung cancer
BRAF mutated melanoma: targeted or immunotherapy?
Rodabe N. Amaria
The successes of novel therapies and molecular testing in lung cancer and patient access
Communication and safety when treating patients undergoing immunotherapy